U.S. Water Utilities Stock News

NasdaqGS:NAVN
NasdaqGS:NAVNHospitality

Navan Booking.com Expansion Tests Growth Story And Valuation Gap

Navan has expanded its partnership and direct API integration with Booking.com, broadening access to lodging options for corporate travelers. The upgrade gives Navan customers access to more properties, including in less conventional destinations, along with exclusive discounted rates. Travel managers gain stronger oversight tools, aimed at improving policy compliance and cost control across corporate travel programs. For investors watching NasdaqGS:NAVN, the Booking.com expansion comes as...
NasdaqGS:DOCU
NasdaqGS:DOCUSoftware

DocuSign AI eSignature Tools Aim To Deepen Platform Stickiness For Investors

DocuSign (NasdaqGS:DOCU) has introduced new AI powered eSignature tools for its Intelligent Agreement Management platform. The update focuses on summarizing complex contract terms and automating document preparation tasks. The features are designed to make agreements clearer for users and reduce manual work for businesses. DocuSign operates at the center of digital agreement workflows, helping companies move contracts and approvals online. The new AI tools fit into a wider push across...
NasdaqGS:CLOV
NasdaqGS:CLOVHealthcare

Clover Health Balances Customer Growth And Cash Flow Against Revenue Pressure

Clover Health Investments (NasdaqGS:CLOV) is reporting strong customer growth for its Medicare Advantage plans and related technology solutions. The company is seeing an expanding free cash flow margin even as revenue has declined over the past two years. This mix of higher customer counts and improving cash generation, alongside revenue pressure, is a fresh development that investors are assessing. Clover Health focuses on Medicare Advantage insurance and technology driven care tools,...
NasdaqGS:DXPE
NasdaqGS:DXPETrade Distributors

Will Trade Tensions and Mixed Earnings Expectations Change DXP Enterprises' (DXPE) Narrative

In recent trading, DXP Enterprises has been caught up in past market volatility tied to shifting U.S. trade tensions and tariff threats, while investors also look ahead to an earnings report that is expected to show lower EPS alongside higher revenue. The stock’s moves highlight how external policy uncertainty can weigh on sentiment even when consensus expectations point to continued sales growth and constructive analyst rankings. We’ll now examine how trade-policy uncertainty and the...
NasdaqGS:CASH
NasdaqGS:CASHBanks

Is It Too Late To Reassess Pathward Financial (CASH) After Its Strong Share Price Run?

If you are wondering whether Pathward Financial is still fairly priced or starting to look expensive at current levels, you are not alone. The stock recently closed at US$85.43, with returns of 13.5% over 7 days, 16.3% over 30 days, 18.9% year to date, 6.9% over 1 year, 76.7% over 3 years and 120.1% over 5 years. This naturally raises questions about how much of the story is already reflected in the price. Recent coverage has focused on how Pathward Financial is positioned within the US...
NasdaqCM:SKYT
NasdaqCM:SKYTSemiconductor

Assessing SkyWater Technology (SKYT) Valuation After A Sharp Multi Month Share Price Surge

Why SkyWater Technology is on investors’ radar SkyWater Technology (SKYT) has drawn fresh attention after a sharp share price move, with the stock up about 78% over the past month and roughly 97% in the past 3 months. See our latest analysis for SkyWater Technology. That sharp 77.9% 1 month share price return and 96.7% 3 month share price return, from a latest share price of $32.35, sits alongside a 1 year total shareholder return of about 230%. This suggests momentum has been building...
NasdaqGM:ALT
NasdaqGM:ALTBiotechs

Altimmune (ALT) Valuation Check After Pemvidutide’s FDA Breakthrough Therapy Designation

FDA Breakthrough designation puts pemvidutide in focus Altimmune (ALT) has drawn fresh attention after the FDA granted Breakthrough Therapy Designation to its lead candidate pemvidutide for MASH, based on mid stage trial data showing significant disease resolution. See our latest analysis for Altimmune. The FDA Breakthrough Therapy news has arrived during a period of building momentum for Altimmune, with the 7 day share price return of 33.49% and year to date share price return of 61.25%...
NasdaqGS:PHVS
NasdaqGS:PHVSPharmaceuticals

Assessing Pharvaris (PHVS) Valuation After Earnings Beat And Renewed Analyst Optimism

Why Pharvaris Stock Is Back on Traders’ Radars Pharvaris (PHVS) has drawn fresh attention after a quarterly earnings report that surpassed analysts’ consensus expectations, followed by multiple brokerages reiterating positive ratings and increasing their estimates for the stock. See our latest analysis for Pharvaris. After the recent earnings surprise and upbeat broker commentary, Pharvaris has kept positive momentum, with a 21.81% 90 day share price return and a 53.11% 1 year total...
NasdaqGS:ARM
NasdaqGS:ARMSemiconductor

Is Arm Holdings (ARM) Pricing In Too Much Growth After Recent Share Price Rebound?

If you are wondering whether Arm Holdings at around US$114.73 is a bargain or already priced for perfection, you are not alone. The stock has moved 7.1% over the last 7 days and 4.0% over the last 30 days, while the 1 year return sits at a 23.2% decline, which can change how investors think about both upside and risk. Recent attention on Arm Holdings has focused on its role at the center of global semiconductor design, with investors watching how its chip architectures power everything from...
NYSE:GBTG
NYSE:GBTGHospitality

Is It Time To Reassess Global Business Travel Group (GBTG) After Recent Share Price Weakness?

Wondering if Global Business Travel Group at US$7.15 is offering value or just extra risk right now? This article walks through what the current price actually implies. The stock has seen a 6% decline over the last week, 8.2% over the last month, and sits 18.9% lower over the past year, with a small 1.4% gain over three years. Recent coverage has focused on Global Business Travel Group as a listed play on corporate and managed travel, with attention on how its scale and business model...
NYSE:WRBY
NYSE:WRBYSpecialty Retail

Warby Parker (WRBY) Valuation In Focus After Strong Quarter And Softer Full Year Revenue Guidance

Why Warby Parker stock is back in focus Warby Parker (WRBY) is drawing fresh attention after its latest quarter paired 15.2% year on year revenue growth and an earnings per share beat with softer full year revenue guidance. See our latest analysis for Warby Parker. That mix of strong quarterly growth and softer guidance has been reflected in the share price, with the stock at $27.38 after a 29.58% 90 day share price return and a 71.88% three year total shareholder return, though near term...
NasdaqGS:DAKT
NasdaqGS:DAKTElectronic

Daktronics HR Exit Raises Questions On Governance And Growth Execution

Daktronics (NasdaqGS:DAKT) announced that Corporate Secretary and Vice President of Human Resources, Carla S. Gatzke, is leaving the company. Her departure affects leadership oversight of human resources and corporate governance functions. Daktronics focuses on electronic scoreboards, large video displays, and digital signage used in sports venues, transportation, and commercial settings. For you as an investor, a change in senior human resources leadership touches on how the company...
NYSE:JBS
NYSE:JBSFood

A Look At JBS (NYSE:JBS) Valuation After Recent Share Price Momentum

Context for JBS (JBS) after recent share moves JBS (JBS) has drawn fresh attention after a recent pullback of about 0.6% in the latest session, alongside gains of roughly 5.9% over the past week and 6.7% over the past month. See our latest analysis for JBS. At a share price of US$15.53, JBS sits on a 90 day share price return of 17.56% and a year to date share price return of 9.52%, suggesting momentum has been building in recent months as investors reassess its risk and growth profile. If...
NYSE:TJX
NYSE:TJXSpecialty Retail

Is TJX Companies (TJX) Still Attractive After Recent Share Price Pullback And Strong Multi‑Year Rally

If you are wondering whether TJX Companies at about US$150 a share still offers value, you are not alone, especially after such a strong long term return profile. The stock is down about 4.6% over the last week and 4.5% over the last month, while it is still up 21.6% over 1 year, 91.9% over 3 years and 152.3% over 5 years. Recent headlines around TJX have focused on its position as a large off price retailer and its role as a major player in U.S. retail. This has kept investor attention on...
NYSE:SM
NYSE:SMOil and Gas

Is SM Energy’s (SM) Cheaper Valuation Offsetting Its Weaker Earnings Outlook?

SM Energy recently drew attention after Zacks assigned it a Rank #5 (Strong Sell), following a decline in consensus earnings estimates that raised questions about its near-term earnings outlook. At the same time, SM Energy’s shares are trading at a discount to peers, creating an unusual mix of weaker earnings expectations and apparently cheaper valuation. With this context in mind, we’ll explore how weaker earnings estimates may influence SM Energy’s investment narrative for investors. The...
NYSE:VSCO
NYSE:VSCOSpecialty Retail

Is Victoria's Secret (VSCO) Stock Price Run Justified By Current Valuation Metrics

If you are wondering whether Victoria's Secret shares still offer value after a strong run, this breakdown is designed to help you weigh what you are paying against what you are getting. The stock last closed at US$58.57, with returns of 8.8% over 30 days and 56.9% over the past year, which has changed how some investors may be thinking about both upside and risk. Recent attention on Victoria's Secret has focused on how the brand is repositioning itself and adjusting its product and...
NasdaqGS:APP
NasdaqGS:APPSoftware

Reassessing AppLovin (APP) After Sharp Pullback And Rich Earnings Multiple

If you are wondering whether AppLovin is still worth the price on your screen, you are not alone. This article will focus squarely on what the current share price might imply about value. The stock recently closed at US$535.44, with a 7 day return of a 5.9% decline, a 30 day return of a 25.0% decline and a year to date return of a 13.4% decline, set against a 1 year return of 56.1% and a very large 3 year return. Recent headlines around AppLovin have kept investor attention on factors such...
NasdaqGS:CORZ
NasdaqGS:CORZSoftware

Assessing Core Scientific (CORZ) Valuation After Options Surge And BTIG Upgrade

Options Surge Puts Core Scientific in Focus Unusual options activity in Core Scientific (CORZ), including a series of large trades highlighted by Benzinga’s scanner, has brought the Bitcoin miner to more investors’ attention this week. See our latest analysis for Core Scientific. At a share price of $19.05, Core Scientific’s recent 24.59% 1 month share price return contrasts with a 5.18% 3 month share price decline. Its 68.88% 1 year total shareholder return points to momentum that has...
NYSE:SGHC
NYSE:SGHCHospitality

Super Group Special Dividend Highlights Confidence In Growth And Cash Flows

Super Group (NYSE:SGHC) declared a special dividend following its full year results, highlighting management’s confidence in the business. The payout comes after the company reported strong performance for the year and record highs in active customers and deposits. The decision adds a shareholder income component on top of Super Group’s existing online sports betting and gaming operations. Super Group, which operates online sports betting and gaming brands, is leaning on a growing base of...
NYSE:HTGC
NYSE:HTGCCapital Markets

Is Hercules Capital (HTGC) Attractively Priced After Recent Share Price Pullback?

If you are wondering whether Hercules Capital is priced attractively right now, you are not alone. Many investors are asking if the current share price lines up with the underlying value. The stock recently closed at US$18.56, with returns of a 1.9% decline over 7 days, a 0.7% decline over 30 days, a 1.6% decline year to date, a 1.6% decline over 1 year and gains of 81.8% over 3 years and 111.6% over 5 years. This naturally raises questions about what is already baked into the price. Recent...
NYSE:SPXC
NYSE:SPXCMachinery

Did Reaffirmed Data Center Cooling Role Just Shift SPX Technologies' (SPXC) Investment Narrative?

In recent weeks, SPX Technologies drew attention as analysts clarified that the company’s cooling tower products remain important for data center heat management, following earlier concerns about changing cooling technologies. This reaffirmation came alongside commentary highlighting SPX Technologies’ role in specialized HVAC and detection equipment, reinforcing its relevance across industrial, commercial, and utility infrastructure markets. We’ll now examine how this reaffirmed role in data...
NasdaqGS:HBT
NasdaqGS:HBTBanks

HBT Financial (HBT) Net Interest Margin Stability Reinforces Bullish Profitability Narratives

HBT Financial (HBT) has wrapped up FY 2025 with fourth quarter revenue of US$59.0 million and basic EPS of US$0.60, while trailing twelve month revenue came in at US$233.9 million and EPS at US$2.44. Over the last few quarters, the company has seen revenue range from US$55.8 million to US$59.2 million per quarter, with quarterly EPS between US$0.58 and US$0.64, giving investors a consistent earnings profile to judge against prior periods. With trailing net profit margins holding in the low...
NasdaqGS:STLD
NasdaqGS:STLDMetals and Mining

Steel Dynamics (STLD) Margin Compression To 6.5% Tests Bullish Earnings Growth Narrative

Steel Dynamics (STLD) has wrapped up FY 2025 with fourth quarter revenue of US$4.4 billion and basic EPS of US$1.83, as the market weighs those figures against a current share price of US$173.32. The company has seen quarterly revenue move from US$3,872 million in Q4 2024 to US$4,414 million in Q4 2025, while basic EPS over that same period shifted from US$1.36 to US$1.83. This is setting the stage for investors to focus closely on how net income trends and margins color the latest set of...
NYSE:FIGS
NYSE:FIGSLuxury

Is FIGS (FIGS) Still Sensibly Priced After A 96% One Year Share Price Surge

If you are wondering whether FIGS at US$11.26 is still attractively priced after its recent run, this article walks through what the numbers are saying about its current value. The stock has delivered a 96.9% return over the last year and 33.6% over three years, even though the past week and month saw returns of 2.9% decline and 4.7% decline, with a 1.1% decline year to date. Recent attention on FIGS has centered on its position in medical apparel and how the brand is competing in a crowded...